Skip to main content
. 2020 Jun 30;5(3):e00178-20. doi: 10.1128/mSystems.00178-20

TABLE 1.

Staphylococcus aureus strains and plasmids used in this study

Strain or plasmid Relevant characteristic(s) Vancomycin
MIC (μg/ml)
Reference(s)
300-169 PBa -MRSA, agr-I SCCmec IV CC45b 0.5 5
301-188 RBa -MRSA, agr-I SCCmec IV CC45 0.5 5
300-169p 300-169 with pALC1766 0.5 13
301-188p 301-188 with pALC1766 0.5 13
301-188p::ϕSA169 301-188 lysogenized with bacteriophage ϕSA169 and transduced with pALC1766 0.5 This study
RN4220 NCTC8325-4, α-hemolysin negative, β-hemolysin positive 5
SH1000 rsbU-positive derivative of NCTC8325-4, agr-I 5
SH1001 SH1000 agr::tet(M) Tetr 5
pALC1766 Derivative of pALC1484 in which the cap5 promoter was cloned upstream of gfpUVR reporter, Chlr 13
a

PB, persistent MRSA bacteremia strain; RB, resolving MRSA bacteremia strain.

b

CC, clonal complex.